High-dose chemotherapy of metastatic breast cancer: The end of the beginning?

被引：7

作者：

Crown, J

机构：

来源：

BRITISH JOURNAL OF CANCER | 1997年 / 75卷 / 04期

关键词：

high-dose chemotherapy; breast cancer;

D O I：

10.1038/bjc.1997.81

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：467 / 469

页数：3

共 38 条

[1] A PHASE-II STUDY OF HIGH-DOSE CYCLOPHOSPHAMIDE, THIOTEPA, AND CARBOPLATIN WITH AUTOLOGOUS MARROW SUPPORT IN WOMEN WITH MEASURABLE ADVANCED BREAST-CANCER RESPONDING TO STANDARD-DOSE THERAPY [J].

ANTMAN, K ;

AYASH, L ;

ELIAS, A ;

WHEELER, C ;

HUNT, M ;

EDER, JP ;

TEICHER, BA ;

CRITCHLOW, J ;

BIBBO, J ;

SCHNIPPER, LE ;

FREI, E .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (01) :102-110

[2] DOUBLE DOSE-INTENSIVE CHEMOTHERAPY WITH AUTOLOGOUS MARROW AND PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT FOR METASTATIC BREAST-CANCER - A FEASIBILITY STUDY [J].

AYASH, LJ ;

ELIAS, A ;

WHEELER, C ;

REICH, E ;

SCHWARTZ, G ;

MAZANEF, R ;

TEPLER, I ;

WARREN, D ;

LYNCH, C ;

GONIN, R ;

SCHNIPPER, L ;

FREI, E ;

ANTMAN, K .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (01) :37-44

[3] Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: A randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group [J].

Bastholt, L ;

Dalmark, M ;

Gjedde, SB ;

Pfeiffer, P ;

Pedersen, D ;

Sandberg, E ;

Kjaer, M ;

Mouridsen, HT ;

Rose, C ;

Nielsen, OS ;

Jakobsen, P ;

Bentzen, SM .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) :1146-1155

[4] RETRACTED: HIGH-DOSE CHEMOTHERAPY WITH HEMATOPOIETIC RESCUE AS PRIMARY-TREATMENT FOR METASTATIC BREAST-CANCER - A RANDOMIZED TRIAL (Retracted article. See vol. 19, pg. 2973, 2001) [J].

BEZWODA, WR ;

SEYMOUR, L ;

DANSEY, RD .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (10) :2483-2489

[5] PERIPHERAL-BLOOD PROGENITOR CELLS MOBILIZED BY CHEMOTHERAPY PLUS GRANULOCYTE-COLONY-STIMULATING FACTOR ACCELERATE BOTH NEUTROPHIL AND PLATELET RECOVERY AFTER HIGH-DOSE VP16, IFOSFAMIDE AND CISPLATIN [J].

BRUGGER, W ;

BIRKEN, R ;

BERTZ, H ;

HECHT, T ;

PRESSLER, K ;

FRISCH, J ;

SCHULZ, G ;

MERTELSMANN, R ;

KANZ, L .

BRITISH JOURNAL OF HAEMATOLOGY, 1993, 84 (03) :402-407

[6] RETRACTED: RECONSTITUTION OF HEMATOPOIESIS AFTER HIGH-DOSE CHEMOTHERAPY BY AUTOLOGOUS PROGENITOR CELLS GENERATED EX-VIVO (RETRACTED ARTICLE. SEE VOL 345, PG 64, 2001) [J].

BRUGGER, W ;

HEIMFELD, S ;

BERENSON, RJ ;

MERTELSANN, R ;

KANZ, L .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (05) :283-287

[7] THE INFLUENCE OF CHEMOTHERAPY ON SURVIVAL AFTER RECURRENCE IN BREAST-CANCER - A POPULATION-BASED STUDY OF PATIENTS TREATED IN THE 1950S, 1960S AND 1970S [J].

COLD, S ;

JENSEN, NV ;

BRINCKER, H ;

ROSE, C .

EUROPEAN JOURNAL OF CANCER, 1993, 29A (08) :1146-1152

[8] RAPID ADMINISTRATION OF MULTIPLE CYCLES OF HIGH-DOSE MYELOSUPPRESSIVE CHEMOTHERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER [J].

CROWN, J ;

KRITZ, A ;

VAHDAT, L ;

REICH, L ;

MOORE, M ;

HAMILTON, N ;

SCHNEIDER, J ;

HARRISON, M ;

GILEWSKI, T ;

HUDIS, C ;

GULATI, S ;

NORTON, L .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (06) :1144-1149

[9] RAPID DELIVERY OF MULTIPLE HIGH-DOSE CHEMOTHERAPY COURSES WITH GRANULOCYTE COLONY-STIMULATING FACTOR AND PERIPHERAL BLOOD-DERIVED HEMATOPOIETIC PROGENITOR CELLS [J].

CROWN, J ;

WASSHERHEIT, C ;

HAKES, T ;

FENNELLY, D ;

REICH, L ;

MOORE, M ;

SCHNEIDER, J ;

CURTIN, J ;

RUBIN, SC ;

REICHMAN, B ;

MOORE, M ;

YAO, TJ ;

GILEWSKI, T ;

GULATI, S ;

MARKMAN, M ;

NORTON, L .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (24) :1935-1936

[10] CARBOPLATIN AND ETOPOSIDE IN METASTATIC BREAST-CANCER [J].

CROWN, J ;

HAMILTON, N ;

RAPTIS, G ;

KRITZ, A ;

VAHDAT, L ;

NORTON, L .

ANNALS OF ONCOLOGY, 1995, 6 (04) :403-403

← 1 2 3 4 →